日本新冠病毒体外膜肺氧合网络（Japan ECMOnet for COVID-19）：针对新冠病毒所致严重呼吸衰竭病例的电话会诊
Japan ECMOnet for COVID-19: telephone consultations for cases with severe respiratory failure caused by COVID-19.
出版信息
J Intensive Care. 2020 Apr 7;8:24. doi: 10.1186/s40560-020-00440-9. eCollection 2020.
Abstract
Recently, the novel coronavirus disease 2019 (COVID-19) started spreading in Japan. Therefore, the number of patients with severe COVID-19 requiring extracorporeal membranous oxygenation (ECMO) is expected to increase. A working group has been formed to provide telephone consultation services for cases with severe respiratory failure caused by COVID-19 in Japan. During the first 13 days of the service, there were 12 consultations. For each consultation, we advised the patient on the initiation of ECMO and arranged transportation for patients with ECMO. Based on experience from the H1N1 influenza pandemic, transporting patients to experienced facilities is essential to obtain better outcomes.
摘要
最近，2019年新型冠状病毒病（COVID-19）开始在日本传播。因此，预计需要体外膜肺氧合（ECMO）的重症COVID-19患者数量将会增加。日本已成立一个工作组，为COVID-19导致的严重呼吸衰竭病例提供电话咨询服务。在服务的前13天里，有12次咨询。对于每次咨询，我们都就启动ECMO事宜为患者提供建议，并为需要使用ECMO的患者安排转运。根据甲型H1N1流感大流行的经验，将患者转运至经验丰富的机构对于获得更好的治疗效果至关重要。
相似文献
1
Japan ECMOnet for COVID-19: telephone consultations for cases with severe respiratory failure caused by COVID-19.日本新冠病毒体外膜肺氧合网络（Japan ECMOnet for COVID-19）：针对新冠病毒所致严重呼吸衰竭病例的电话会诊
J Intensive Care. 2020 Apr 7;8:24. doi: 10.1186/s40560-020-00440-9. eCollection 2020.
2
Establishment of a Disaster Management-like System for COVID-19 Patients Requiring Veno-Venous Extracorporeal Membrane Oxygenation in Japan.日本为需要静脉-静脉体外膜肺氧合的新冠肺炎患者建立类似灾害管理的系统
Membranes (Basel). 2021 Aug 14;11(8):625. doi: 10.3390/membranes11080625.
3
[Study on the extracorporeal membrane oxygenation inter-hospital transport during coronavirus disease 2019 epidemic: based on the transport experience of 6 cases of severe H1N1 influenza virus pneumonia on extracorporeal membrane oxygenation].新型冠状病毒肺炎疫情期间体外膜肺氧合院际转运的研究：基于6例体外膜肺氧合治疗的重症甲型H1N1流感病毒肺炎患者的转运经验
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Apr;32(4):430-434. doi: 10.3760/cma.j.cn121430-20200309-00413.
4
The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: preparation for severe respiratory emergency outbreaks.意大利体外膜肺氧合网络在 2009 年甲型 H1N1 流感大流行期间的经验：为严重呼吸道紧急疫情爆发做准备。
Intensive Care Med. 2011 Sep;37(9):1447-57. doi: 10.1007/s00134-011-2301-6. Epub 2011 Jul 6.
5
Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) severe respiratory failure in Japan.日本应用体外膜肺氧合治疗 2009 年甲型 H1N1 流感所致严重呼吸衰竭
J Anesth. 2012 Oct;26(5):650-7. doi: 10.1007/s00540-012-1402-x. Epub 2012 May 23.
6
Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort study.体外膜肺氧合治疗 COVID-19 和 H1N1 流感相关急性呼吸窘迫综合征：一项多中心回顾性队列研究。
Crit Care. 2022 Feb 5;26(1):34. doi: 10.1186/s13054-022-03906-4.
7
Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score.预测甲型 H1N1 流感肺炎所致急性呼吸窘迫综合征行静脉-静脉体外膜肺氧合患者的死亡率：ECMONet 评分。
Intensive Care Med. 2013 Feb;39(2):275-81. doi: 10.1007/s00134-012-2747-1. Epub 2012 Nov 16.
8
Extracorporeal membrane oxygenation for 2009 influenza A (H1N1) acute respiratory distress syndrome: single-centre experience with 1-year follow-up.体外膜肺氧合治疗 2009 年甲型 H1N1 流感急性呼吸窘迫综合征：单中心 1 年随访经验。
Eur J Cardiothorac Surg. 2012 Mar;41(3):691-5. doi: 10.1093/ejcts/ezr082. Epub 2012 Jan 6.
9
The Evolution of the Use of Extracorporeal Membrane Oxygenation in Respiratory Failure.体外膜肺氧合在呼吸衰竭治疗中的应用进展
Membranes (Basel). 2021 Jun 30;11(7):491. doi: 10.3390/membranes11070491.
10
Clinical Characteristics, Complications and Outcomes of Patients with Severe Acute Respiratory Distress Syndrome Related to COVID-19 or Influenza Requiring Extracorporeal Membrane Oxygenation-A Retrospective Cohort Study.与新型冠状病毒肺炎或流感相关的严重急性呼吸窘迫综合征患者接受体外膜肺氧合治疗的临床特征、并发症及预后——一项回顾性队列研究
J Clin Med. 2021 Nov 21;10(22):5440. doi: 10.3390/jcm10225440.
引用本文的文献
1
A scoping review of patient engagement activities during COVID-19: More consultation, less partnership.一项关于 COVID-19 期间患者参与活动的范围综述：更多的咨询，更少的合作。
PLoS One. 2021 Sep 29;16(9):e0257880. doi: 10.1371/journal.pone.0257880. eCollection 2021.
2
Establishment of a Disaster Management-like System for COVID-19 Patients Requiring Veno-Venous Extracorporeal Membrane Oxygenation in Japan.日本为需要静脉-静脉体外膜肺氧合的新冠肺炎患者建立类似灾害管理的系统
Membranes (Basel). 2021 Aug 14;11(8):625. doi: 10.3390/membranes11080625.
3
Barriers to Use of Remote Monitoring Technologies Used to Support Patients With COVID-19: Rapid Review.用于支持 COVID-19 患者的远程监测技术使用障碍：快速综述。
JMIR Mhealth Uhealth. 2021 Apr 20;9(4):e24743. doi: 10.2196/24743.
4
Critical Care Demand and Intensive Care Supply for Patients in Japan with COVID-19 at the Time of the State of Emergency Declaration in April 2020: A Descriptive Analysis.2020年4月紧急状态声明发布时日本新冠肺炎患者的重症监护需求与重症监护供应情况：描述性分析
Medicina (Kaunas). 2020 Oct 12;56(10):530. doi: 10.3390/medicina56100530.
5
Mobile ECMO in COVID-19 patient: case report.移动 ECMO 在 COVID-19 患者中的应用：病例报告。
J Artif Organs. 2021 Jun;24(2):287-292. doi: 10.1007/s10047-020-01209-5. Epub 2020 Sep 19.
6
Post-COVID-19 precautions based on lessons learned from past pandemics: a review.基于以往大流行经验教训的新冠后预防措施：综述
Z Gesundh Wiss. 2022;30(4):973-981. doi: 10.1007/s10389-020-01371-3. Epub 2020 Aug 4.
7
Save the ICU and save lives during the COVID-19 pandemic.在新冠疫情期间拯救重症监护病房并拯救生命。
J Intensive Care. 2020 Jun 15;8:40. doi: 10.1186/s40560-020-00456-1. eCollection 2020.
8
Nationwide system to centralize decisions around extracorporeal membranous oxygenation use for severe COVID-19 pneumonia in Japan.日本用于严重COVID-19肺炎体外膜肺氧合使用决策的全国性系统。
Acute Med Surg. 2020 Apr 21;7(1):e510. doi: 10.1002/ams2.510. eCollection 2020 Jan-Dec.
9
Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan (Special Correspondence).日本全国范围内集中决策使用体外膜肺氧合治疗重症新冠肺炎的系统（特别报道）
J Intensive Care. 2020 Apr 24;8:29. doi: 10.1186/s40560-020-00445-4. eCollection 2020.
本文引用的文献
1
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
2
Comparison of extracorporeal membrane oxygenation outcome for influenza-associated acute respiratory failure in Japan between 2009 and 2016.2009年至2016年日本流感相关急性呼吸衰竭体外膜肺氧合治疗结果的比较。
J Intensive Care. 2018 Jul 11;6:38. doi: 10.1186/s40560-018-0306-8. eCollection 2018.
3
Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality. Analysis of the extracorporeal life support organization registry.医院体外膜肺氧合病例数量与死亡率的关联。体外生命支持组织登记处分析。
Am J Respir Crit Care Med. 2015 Apr 15;191(8):894-901. doi: 10.1164/rccm.201409-1634OC.
4
Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) severe respiratory failure in Japan.日本应用体外膜肺氧合治疗 2009 年甲型 H1N1 流感所致严重呼吸衰竭
J Anesth. 2012 Oct;26(5):650-7. doi: 10.1007/s00540-012-1402-x. Epub 2012 May 23.
5
Extracorporeal membrane oxygenation for pandemic H1N1 2009 respiratory failure.体外膜肺氧合治疗 2009 年甲型 H1N1 流感所致呼吸衰竭。
Minerva Anestesiol. 2010 Dec;76(12):1043-51.
6
Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.常规通气支持与体外膜肺氧合治疗成人严重呼吸衰竭的疗效及经济学评估（CESAR）：一项多中心随机对照试验
Lancet. 2009 Oct 17;374(9698):1351-63. doi: 10.1016/S0140-6736(09)61069-2. Epub 2009 Sep 15.
Zotero 插件